Research Antibodies Market

Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022

Report Code: BT 5482 Aug, 2017, by marketsandmarkets.com

[279 Pages Report] The overall research antibodies and reagents market is expected to grow from USD 9.33 billion in 2017 to USD 12.60 billion by 2022, at a CAGR of 6.2% from 2017 to 2022. Research-use antibodies and reagents are integral components in the field of life science research for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. The growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and the increasing R&D activities and expenditure in the life sciences industry are aiding the growth of the market. The growing demand for protein therapeutics and personalized medicine, coupled with the development of newly engineered proteins, is expected to open growth avenues for research markets in terms of the uptake of antibodies and reagents. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

Market Dynamics

Drivers

  • Increasing R&D activity and funding for R&D
  • Growing industry-acedemia collaborations

 

Opportunities

  • High growth opportunities in emerging markets
  • Increasing demand for personalized medicine and protein therpaeutics
  • Growth in stem cell and neurobiology research
  • Increasing focus on biomarker discovery

Challenges

  • Quality concerns over research antibodies
  • Cost- and time-intensive antibody development processes
  • Pricing pressure faced by prominent market players  

Increasing stem cell and neurobiology research provide significant growth opportunities<

Antibodies are a powerful tool for characterizing, isolating, and analyzing stem cells and their derivatives. Through the use of flow cytometry, antibodies help researchers obtain population-based statistics and multi-parametric data on differentiating stem cell cultures, and it also allows them to isolate stem cells by using multiple fluorescent-labeled antibodies. The large stem cell product pipelines of several major companies and applications of stem cells in the treatment of various diseases are driving stem cell research activities globally. Also, Neurobiology research relies on antibodies to identify and elucidate reactions on a cellular, molecular, or biochemical level, thus enabling the better understanding of neuroscience processes and neuronal diseases. With the increasing incidence of various neurological disorders, a number of research activities are being undertaken in this field. This will offer significant growth opportunities to market players focusing on developing stem cell and neuroscience research antibodies.

The following are the major objectives of the study.

  • To define, describe, segment, and forecast the global research antibodies and reagents market, on the basis of product, technology, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the global research antibodies and reagents market, in five main regions (along with countries) North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle-East and Africa (MEA)
  • To profile key players in the global research antibodies and reagents market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as new product/technology developments partnerships; mergers and acquisitions; expansions; and R&D activities of the leading players in the research antibodies and reagents market

During this research study, major players operating in the research antibodies and reagents market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Research Antibodies Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), GenScript (US), PerkinElmer, Inc. (US), Lonza (Switzerland), and BioLegend, Inc. (US).

Major Market Developments

  • In January 2017, Merck expanded its end-to-end bio-development centers in North America, China, and Europe to meet increasing customer demand and also to increase its manufacturing capabilities.
  • In March 2016, Thermo Fisher Scientific (US) acquired Affymetrix, Inc. (US) expanding the company’s research antibody portfolio, and strengthening its leadership in the biosciences business. It also helped Thermo Fisher add new genetic analysis capabilities in the clinical and applied markets.
  • In April 2016, Abcam launched a suite of immunoassay, products based on recombinant monoclonal antibody pairs used in ELISA to study secreted biomarkers by life science researchers

Target Audience:

  • Pharmaceutical and Biotechnology Companies
  • Life Sciences Companies
  • Academic Research Institutes
  • Government Institutes
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Venture Capitalists and Investors

Report Scope

Global Research Antibodies Market, by Product

  • Antibodies
    • Antibodies Market, by Type
      • Primary Antibodies
      • Secondary Antibodies
    • Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Others
    • Antibodies Market, by Research Area
      • Oncology
      • Infectious Diseases
      • Neurobiology
      • Stem Cell
      • Immunology
      • Others
  • Reagents
    • Stains & Dyes
    • Media & Sera
    • Fixatives
    • Buffers
    • Probes
    • Solvents
    • Enzymes
    • Others

Global Research Antibodies Market, by Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-linked Immunosorbent Assay
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Others

Global Research Antibodies Market, by Application

  • Proteomics
  • Drug Development
  • Genomics

Global Research Antibodies Market, by End User

  • Pharmaceutical & Biotechnological Companies
  • Academic & Research Institutes
  • Contract Research Organizations

Global Research Antibodies Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

Critical questions which the report answers

  • What are new technology areas which the research antibody companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific’s research antibodies market into South Korea, Australia, New Zealand, and other Asian countries
  • Further breakdown of the Latin American research antibodies market into Brazil, Argentina, and other Latin American countries.

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The overall research antibodies market is expected to grow from USD 9.33 billion in 2017 to USD 12.60 billion by 2022 at a CAGR of 6.2%. The growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and the increasing R&D activities and expenditure in the life sciences industry are the key factors driving the growth of this market.

Research-use antibodies and reagents are integral components in the field of life science research for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. They are extensively used for the characterization of proteins and nucleic acids for proteomic and genomic research. Due to their high specificity and selectivity, antibodies have great potential as research tools in a wide range of biochemical and medical research applications. Research-use antibodies are majorly used for protein-target identification, regulatory characterization, and discovery, and continue to be the gold-standard choice for protein identification, detection, modification, and alteration, as well as for monitoring expression and cellular regulation. Over the years, with the increasing research being held in various fields the market for research antibodies and reagents has witnessed significant growth.

The research antibodies and reagents market has been segmented, on the basis of product, into reagents and antibodies. The market for antibodies is expected to grow at the highest CAGR between 2018 and 2023. On the other hand, among all the reagents, stains and dyes are being widely used. Their high adoption for enhanced visualization in cell biology, molecular, and histological studies is increasing with the growth in the life science research industry.

On the basis of technology, western blotting segment held the largest share of the global market due to the high adoption of this technique in proteomic and genomic research, as it can accurately show the presence of a specific protein, both by size and through binding of an antibody. Also, the results achieved are easy to interpret, unique, and unambiguous, making it well-suited for evaluating levels of protein expression in cells, monitoring fractions during protein purification, and for comparing expression of a target protein from various tissues.

The pharmaceutical & biotechnology companies hold a significant share of the market by end user. This can be attributed to the wide use of research antibodies in the drug development process, for the identification and quantification of biomarkers, and in various analytical procedures.

The research antibodies and reagents market in APAC is expected to grow at the highest CAGR during the forecast period.  The high growth of this segment is primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region.

Research Antibodies Market

Proteomics research in drive the growth of research antibodies and reagents market

Proteomics

Proteomics refers to the experimental analysis of proteins, along with its purification and mass spectrometry studies. These studies require the generation of specific and high-affinity antibodies against large numbers of proteins to study their expression and function. The availability of thoroughly validated antibodies helps in understanding the protein expression, localization, function, and fundamental processes of living organisms. Antibody-based proteomics is imperative for biomarker discovery and validation, facilitating the high-throughput evaluation of candidate markers. These markers are used in the early detection of diseases, such as cancer, Alzheimer’s, and immunological disorders, while providing diagnostic and prognostic information.

Drug Development <

Successful drug discovery is dependent on the correct identification of a target implicated in disease, followed by the successful selection, optimization, and development of a candidate drug. Due to their specific binding characteristics with regard to specificity, affinity, and avidity, along with their amenability to protein engineering, antibodies have become a key tool in drug discovery, enabling the quantification, localization, and modulation of proteins of interest. Antibodies are utilized throughout the drug discovery process—from target identification to patient stratification. They are used to investigate target distribution, subcellular localization, function, and more importantly how these factors play a role in the disease pathway.

Genomics

Research in the genomics field involves the use of antibodies to understand the aspects of gene transcription, translation, protein-protein interactions, and 3D structure of every protein encoded by a given genome; study of epigenetic modifications; and structure determination using a combination of experimental and modeling approaches. Antibodies thus play a pivotal role in gene expression and regulation studies.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry technologies in this market?

Variations in antibody production techniques have resulted in a lack of reproducibility of results. Batch variations are subject to variations from animal to animal and purification to purification, and there are no standards for their validation nor agreed-upon definitions of reproducibility across all antibody offerings. These batch-to-batch variations hold true for monoclonal antibodies, but to a much larger extent, this is the case for polyclonal antibodies. The lot-to-lot variability of these antibodies significantly affects the results of basic and fundamental research and clinical screening tests. Thus, research-use antibodies need proper validation before being used in scientific research. With the growing focus on antibody quality, research reproducibility, and technological advancements, the vendors need to ultimately offer higher quality products in the market.

Key players in the market include Thermo Fisher Scientific Inc. (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), PerkinElmer, Inc. (US), Lonza (Switzerland), GenScript (China), and BioLegend, Inc. (US).. These players are increasingly undertaking product launches to develop and introduce new technologies, expansions, mergers and acquisitions, and agreements to alleviate their market position.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders
    1.6 Limitations

2 Research Methodology (Page No. - 22)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Break Down of Primaries
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 39)
    4.1 Market Overview
    4.2 Geographic Growth Opportunities
    4.3 Regional Mix: Research Antibodies and Reagents Market
    4.4 Europe: Research Antibodies Market, By Research Area
    4.5 Developed vs Developing Markets

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Increasing Research Activity, Funding for R&D
                    5.2.1.2 Growing Industry-Academia Collaborations
           5.2.2 Key Market Opportunities
                    5.2.2.1 High Growth Opportunities in Emerging Markets
                    5.2.2.2 Increasing Demand for Personalized Medicine and Protein Therapeutics
                    5.2.2.3 Growth in Stem Cell and Neurobiology Research
                    5.2.2.4 Increasing Focus on Biomarker Discovery
           5.2.3 Key Challenges
                    5.2.3.1 Quality Concerns Over Research Antibodies
                    5.2.3.2 Cost- and Time-Intensive Antibody Development Processes
                    5.2.3.3 Pricing Pressure Faced By Prominent Market Players

6 Research Antibodies Market, By Product (Page No. - 52)
    6.1 Introduction
    6.2 Reagents
           6.2.1 Media & Sera
           6.2.2 Stains & Dyes
           6.2.3 Fixatives
           6.2.4 Buffers
           6.2.5 Solvents
           6.2.6 Enzymes
           6.2.7 Probes
           6.2.8 Other Reagents
    6.3 Antibodies
           6.3.1 Antibodies, By Type
                    6.3.1.1 Primary Antibodies
                    6.3.1.2 Secondary Antibodies
           6.3.2 Antibodies, By Source
                    6.3.2.1 Mice
                    6.3.2.2 Rabbits
                    6.3.2.3 Other Sources
           6.3.3 Antibodies, By Research Area
                    6.3.3.1 Oncology
                    6.3.3.2 Infectious Diseases
                    6.3.3.3 Immunology
                    6.3.3.4 Neurobiology
                    6.3.3.5 Stem Cells
                    6.3.3.6 Other Research Areas

7 Research Antibodies Market, By Technology (Page No. - 83)
    7.1 Introduction
    7.2 Western Blotting
    7.3 Flow Cytometry
    7.4 Enzyme-Linked Immunosorbent Assay (ELISA)
    7.5 Immunohistochemistry
    7.6 Immunofluorescence
    7.7 Immunoprecipitation
    7.8 Other Technologies

8 Research Antibodies Market, By Application (Page No. - 97)
    8.1 Introduction
    8.2 Proteomics
    8.3 Drug Development
    8.4 Genomics

9 Research Antibodies Market, By End User (Page No. - 104)
    9.1 Introduction
    9.2 Pharmaceutical and Biotechnology Companies
    9.3 Academic and Research Institutes
    9.4 Contract Research Organizations

10 Research Antibodies Market, By Region (Page No. - 110)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific (RoAPAC)
     10.5 Latin America
     10.6 Middle East and Africa

11 Competitive Landscape (Page No. - 193)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Leadership Mapping
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Competitive Benchmarking
             11.4.1 Strength of Product Portfolio (For 25 Players)
             11.4.2 Business Strategies Excellence (For 25 Players)

*Top 25 Companies Analysed for This Study are - Thermo Fisher Scientific Inc. (U.S.), Abcam PLC (U.K.), Merck Group (Germany), Becton, Dickinson and Company (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Genscript (U.S.), Perkinelmer, Inc. (U.S.), Lonza (Switzerland), Biolegend, Inc. (U.S.), Qiagen N.V. (Netherlands), Bio Sb (U.S.), Sysmex Corporation (Japan), Jackson Immunoresearch, Inc. (U.S.), Origene Technologies, Inc. (U.S.), Bethyl Laboratories, Inc. (U.S.), Miltenyl Biotec (Germany), Affinity Biologicals Inc. (Canada), Active Motif (U.S.), Enzo Life Sciences, Inc. (U.S.), Rockland Immunochemicals, Inc. (U.S.), Himedia Laboratories (India)

12 Company Profiles (Page No. - 201)
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
     12.1 Thermo Fisher Scientific Inc.
     12.2 Merck Group
     12.3 Abcam PLC
     12.4 Becton, Dickinson and Company
     12.5 Cell Signaling Technology, Inc.
     12.6 Bio-Rad Laboratories, Inc.
     12.7 F. Hoffmann-La Roche Ltd
     12.8 Agilent Technologies, Inc.
     12.9 Danaher Corporation
     12.10 Lonza
     12.11 Genscript
     12.12 Perkinelmer, Inc.
     12.13 Biolegend, Inc.

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 267)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (187 Tables)

Table 1 Key Market Drivers: Impact Analysis
Table 2 Key Market Opportunities: Impact Analysis
Table 3 Key Market Challenges: Impact Analysis
Table 4 Global Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 5 Global Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 6 Global Research Reagents Market, By Country, 2015–2022 (USD Million)
Table 7 Global Research Reagents Market for Media & Sera, By Country, 2015–2022 (USD Million)
Table 8 Global Research Reagents Market for Stains & Dyes, By Country, 2015–2022 (USD Million)
Table 9 Global Research Reagents Market for Fixatives, By Country, 2015–2022 (USD Million)
Table 10 Global Research Reagents Market for Buffers, By Country, 2015–2022 (USD Million)
Table 11 Global Research Reagents Market for Solvents, By Country, 2015–2022 (USD Million)
Table 12 Global Research Reagents Market for Enzymes, By Country, 2015–2022 (USD Million)
Table 13 Global Research Reagents Market for Probes, By Country, 2015–2022 (USD Million)
Table 14 Global Research Reagents Market for Other Reagents, By Country, 2015–2022 (USD Million)
Table 15 Global Research Antibodies Market, By Country, 2015–2022 (USD Million)
Table 16 Global Research Antibodies Market, By Type, 2015–2022 (USD Million)
Table 17 Global Research Antibodies Market for Primary Antibodies, By Country, 2015–2022 (USD Million)
Table 18 Global Research Antibodies Market for Secondary Antibodies, By Country, 2015–2022 (USD Million)
Table 19 Global Research Antibodies Market, By Source, 2015–2022 (USD Million)
Table 20 Global Research Antibodies Market for Mice, By Mice, 2015–2022 (USD Million)
Table 21 Global Research Antibodies Market for Rabbits, By Country, 2015–2022 (USD Million)
Table 22 Global Research Antibodies Market for Other Sources, By Country, 2015–2022 (USD Million)
Table 23 Global Research Antibodies Market, By Research Area, 2015–2022 (USD Million)
Table 24 Global Research Antibodies Market for Oncology, By Country, 2015–2022 (USD Million)
Table 25 Global Research Antibodies Market for Infectious Diseases, By Country, 2015–2022 (USD Million)
Table 26 Global Research Antibodies Market for Immunology, By Country, 2015–2022 (USD Million)
Table 27 Global Research Antibodies Market for Neurobiology, By Country, 2015–2022 (USD Million)
Table 28 Global Research Antibodies Market for Stem Cells, By Country, 2015–2022 (USD Million)
Table 29 Global Research Antibodies Market for Other Research Areas, By Country, 2015–2022 (USD Million)
Table 30 Global Research Antibodies and Reagents Market, By Technology, 2015-2022 (USD Million)
Table 31 Global Research Antibodies and Reagents Market for Western Blotting, By Country, 2015-2022 (USD Million)
Table 32 Global Research Antibodies and Reagents Market for Flow Cytometry, By Country, 2015-2022 (USD Million)
Table 33 Global Research Antibodies and Reagents Market for ELISA, By Country, 2015-2022 (USD Million)
Table 34 Global Research Antibodies and Reagents Market for Immunohistochemistry, By Country, 2015-2022 (USD Million)
Table 35 Global Research Antibodies and Reagents Market for Immunofluorescence, By Country, 2015-2022 (USD Million)
Table 36 Global Research Antibodies and Reagents Market for Immunoprecipitation, By Country, 2015-2022 (USD Million)
Table 37 Global Research Antibodies and Reagents Market for Other Technologies, By Country, 2015-2022 (USD Million)
Table 38 Global Research Antibodies and Reagents Market Size, By Application, 2015–2022 (USD Million)
Table 39 Technological Applications of Antibodies in Proteomics
Table 40 Global Research Antibodies and Reagents Market for Proteomics, By Country, 2015–2022 (USD Million)
Table 41 Global Research Antibodies and Reagents Market for Drug Development, By Country, 2015–2022 (USD Million)
Table 42 Global Research Antibodies and Reagents Market for Genomics, By Country, 2015–2022 (USD Million)
Table 43 Global Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 44 Global Research Antibodies and Reagents Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 45 Global Research Antibodies and Reagents Market for Academic and Research Institutes, By Country, 2015–2022 (USD Million)
Table 46 Global Research Antibodies and Reagents Market for Contract Research Organizations, By Country, 2015–2022 (USD Million)
Table 47 Global Research Antibodies and Reagents Market, By Region, 2015–2022 (USD Million)
Table 48 North America: Research Antibodies and Reagents Market, By Country, 2015–2022 (USD Million)
Table 49 North America: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 50 North America: Research Antibodies Market, By Type, 2015–2022 (USD Million)
Table 51 North America: Market, By Source, 2015–2022 (USD Million)
Table 52 North America: Market, By Research Area, 2015–2022 (USD Million)
Table 53 North America: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 54 North America: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 55 North America: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 56 North America: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 57 The Table Given Below Indicates the Nih Budget for Various Disciplines in Fy 2015 and Fy 2016:
Table 58 U.S.: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 59 U.S.: Market, By Type, 2015–2022 (USD Million)
Table 60 U.S.: Market, By Source, 2015–2022 (USD Million)
Table 61 U.S.: Market, By Research Area, 2015–2022 (USD Million)
Table 62 U.S.: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 63 U.S.: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 64 U.S.: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 65 U.S.: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 66 Canada: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 67 Canada: Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Market, By Source, 2015–2022 (USD Million)
Table 69 Canada: Market, By Research Area, 2015–2022 (USD Million)
Table 70 Canada: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 71 Canada: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 72 Canada: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 73 Canada: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 74 Europe: Research Antibodies and Reagents Market, By Country, 2015–2022 (USD Million)
Table 75 Europe: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 76 Europe: Market, By Type, 2015–2022 (USD Million)
Table 77 Europe: Market, By Source, 2015–2022 (USD Million)
Table 78 Europe: Market, By Research Area, 2015–2022 (USD Million)
Table 79 Europe: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 80 Europe: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 81 Europe: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 82 Europe: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 83 Germany: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 84 Germany: Market, By Type, 2015–2022 (USD Million)
Table 85 Germany: Research Antibodies Market, By Source, 2015–2022 (USD Million)
Table 86 Germany: Market, By Research Area, 2015–2022 (USD Million)
Table 87 Germany: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 88 Germany: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 89 Germany: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 90 Germany: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 91 U.K.: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 92 U. K.: Market, By Type, 2015–2022 (USD Million)
Table 93 U.K.: Market, By Source, 2015–2022 (USD Million)
Table 94 U. K.: Market, By Research Area, 2015–2022 (USD Million)
Table 95 U. K.: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 96 U.K.: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 97 U.K.: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 98 U.K.: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 99 France: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 100 France: Market, By Type, 2015–2022 (USD Million)
Table 101 France: Market, By Source, 2015–2022 (USD Million)
Table 102 France: Market, By Research Area, 2015–2022 (USD Million)
Table 103 France: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 104 France: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 105 France: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 106 France: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 107 Italy: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 108 Italy: Market, By Type, 2015–2022 (USD Million)
Table 109 Italy: Market, By Source, 2015–2022 (USD Million)
Table 110 Italy: Market, By Research Area, 2015–2022 (USD Million)
Table 111 Italy: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 112 Italy: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 113 Italy: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 114 Italy: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 115 Spain: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 116 Spain: Market, By Type, 2015–2022 (USD Million)
Table 117 Spain: Market, By Source, 2015–2022 (USD Million)
Table 118 Spain: Market, By Research Area, 2015–2022 (USD Million)
Table 119 Spain: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 120 Spain: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 121 Spain: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 122 Spain: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 123 RoE: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 124 RoE: Market, By Type, 2015–2022 (USD Million)
Table 125 RoE: Market, By Source, 2015–2022 (USD Million)
Table 126 RoE: Market, By Research Area, 2015–2022 (USD Million)
Table 127 RoE: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 128 RoE: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 129 RoE: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 130 RoE: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 131 Asia-Pacific: Research Antibodies and Reagents Market, By Country, 2015–2022 (USD Million)
Table 132 Asia-Pacific: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 133 Asia-Pacific: Research Antibodies Market, By Type, 2015–2022 (USD Million)
Table 134 Asia-Pacific: Market, By Source, 2015–2022 (USD Million)
Table 135 Asia-Pacific: Market, By Research Area, 2015–2022 (USD Million)
Table 136 Asia-Pacific: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 137 Asia-Pacific: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 138 Asia-Pacific: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 139 Asia-Pacific: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 140 Japan: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 141 Japan: Market, By Type, 2015–2022 (USD Million)
Table 142 Japan: Market, By Source, 2015–2022 (USD Million)
Table 143 Japan: Market, By Research Area, 2015–2022 (USD Million)
Table 144 Japan: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 145 Japan: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 146 Japan: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 147 Japan: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 148 China: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 149 China: Research Antibodies Market, By Type, 2015–2022 (USD Million)
Table 150 China: Market, By Source, 2015–2022 (USD Million)
Table 151 China: Market, By Research Area, 2015–2022 (USD Million)
Table 152 China: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 153 China: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 154 China: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 155 China: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 156 India: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 157 India: Market, By Type, 2015–2022 (USD Million)
Table 158 India: Market, By Source, 2015–2022 (USD Million)
Table 159 India: Market, By Research Area, 2015–2022 (USD Million)
Table 160 India: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 161 India: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 162 India: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 163 India: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 164 RoAPAC: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 165 RoAPAC: Market, By Type, 2015–2022 (USD Million)
Table 166 RoAPAC: Market, By Source, 2015–2022 (USD Million)
Table 167 RoAPAC: Market, By Research Area, 2015–2022 (USD Million)
Table 168 RoAPAC: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 169 RoAPAC: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 170 RoAPAC: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 171 RoAPAC: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 172 Latin America: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 173 Latin America: Market, By Type, 2015–2022 (USD Million)
Table 174 Latin America: Market, By Source, 2015–2022 (USD Million)
Table 175 Latin America: Market, By Research Area, 2015–2022 (USD Million)
Table 176 Latin America: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 177 Latin America: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 178 Latin America: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 179 Latin America: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)
Table 180 Middle East & Africa: Research Antibodies and Reagents Market, By Product, 2015–2022 (USD Million)
Table 181 Middle East & Africa: Market, By Type, 2015–2022 (USD Million)
Table 182 Middle East & Africa: Market, By Source, 2015–2022 (USD Million)
Table 183 Middle East & Africa: Market, By Research Area, 2015–2022 (USD Million)
Table 184 Middle East & Africa: Research Reagents Market, By Type, 2015–2022 (USD Million)
Table 185 Middle East & Africa: Research Antibodies and Reagents Market, By Technology, 2015–2022 (USD Million)
Table 186 Middle East & Africa: Research Antibodies and Reagents Market, By Application, 2015–2022 (USD Million)
Table 187 Middle East & Africa: Research Antibodies and Reagents Market, By End User, 2015–2022 (USD Million)


List of Figures (42 Figures)

Figure 1 Global Research Antibodies and Reagents Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom Up Approach
Figure 5 Top Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Research Antibodies and Reagents Market, By Product, 2017 vs 2022 (USD Million)
Figure 8 Global Research Antibodies Market, By Type, 2017 vs 2022 (USD Million)
Figure 9 Global Research Reagents Market, By Type, 2017 vs 2022 (USD Million)
Figure 10 Global Research Antibodies and Reagents Market, By Technology, 2017 vs 2022 (USD Million)
Figure 11 Global Research Antibodies and Reagents Market, By Application, 2017 vs 2022 (USD Million)
Figure 12 Global Research Antibodies and Reagents Market, By End User, 2017 vs 2022 (USD Million)
Figure 13 Geographic Analysis
Figure 14 Increase in R&D Expenditure in the Life Sciences Industry–Major Factor Driving the Growth of the Research Antibodies and Reagents Market in the Forecast Period
Figure 15 The U.S. Dominated the Global Research Antibodies and Reagents Market in 2016
Figure 16 APAC to Register the Highest Growth Rate in the Research Antibodies and Reagents Market From 2017 to 2022
Figure 17 Oncology Segment Accounted for the Largest Share of the European Research Antibodies Market in 2016
Figure 18 Developing Markets to Register A Higher Growth Rate in the Forecast Period
Figure 19 Drivers, Opportunities, and Challenges
Figure 20 Number of Personalized Medicine Products, 2008–2016
Figure 21 Reagents Segment to Dominate the Research Antibodies and Reagents Market
Figure 22 Western Blotting Forms the Largest Technology Segment in the Research Antibodies and Reagents Market
Figure 23 Proteomics Forms the Largest Application Segment in the Research Antibodies and Reagents Market
Figure 24 Application of Antibodies in the Drug Development Process
Figure 25 Pharmaceutical and Biotechnology Companies Form the Largest End User Segment in the Research Antibodies and Reagents Market
Figure 26 Geographic Snapshot (2016)
Figure 27 North America: Research Antibodies and Reagents Market Snapshot
Figure 28 Europe: Research Antibodies and Reagents Market Snapshot
Figure 29 Asia-Pacific: Research Antibodies and Reagents Market Snapshot
Figure 30 Global Research Antibodies Market Share Analysis, By Key Player, 2016
Figure 31 Competitive Leadership Mapping (2017)
Figure 32 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 33 Merck Group: Company Snapshot (2016)
Figure 34 Abcam PLC: Company Snapshot (2016)
Figure 35 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 36 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 37 F. Hoffmann-La Roche Ltd: Company Snapshot (2016)
Figure 38 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 39 Danaher Corporation: Company Snapshot (2016)
Figure 40 Lonza: Company Snapshot (2016)
Figure 41 Genscript: Company Snapshot (2016)
Figure 42 Perkinelmer, Inc.: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 5482
Published ON
Aug, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Research Antibodies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved